期刊文献+

宫颈癌人乳头瘤病毒感染与CD4^+CD25^+Foxp3^+调节性T细胞的相关性研究 被引量:8

Correlation of Human Papilloma Virus and CD4^+CD25^+Foxp3^+Treg in cervical cancer
下载PDF
导出
摘要 目的探讨宫颈癌人乳头瘤病毒(HPV)感染与T细胞亚群、CD4+CD25+Foxp3+调节性T细胞(Treg)的相关性。方法采用HPV核酸扩增分型检测试剂盒及流式细胞术检测宫颈癌组(40例)、正常对照组(20例)的HPV分型和外周血中T细胞亚群及CD4+CD25+Foxp3+Treg的百分率。结果 HPV阳性的患者外周血T细胞亚群与HPV阴性的患者比较,差异无统计学意义(P>0.05),但调节性T细胞(Treg)在HPV阳性与阴性组之间比较,差异有统计学意义(P<0.05)。宫颈癌组外周血中CD4+CD25+Foxp3+Treg的百分率与正常对照组比较,差异有统计学意义(P<0.05)。HPV与CD4+CD25+Foxp3+Treg细胞呈显著正相关(r=0.613,P<0.05)。结论宫颈癌患者免疫功能与正常人无明显差异,Treg细胞与宫颈癌患者HPV持续感染、肿瘤免疫逃避密切相关。 Objective To investigate the correlation between human papilloma virus (HPV) and T cell subgroup, CD4 + CD25+ Foxp3+ T regulatory cell. Methods 40 patients with cervical cancer and 20 normal controls were involved in this study. Typing of HPV was evaluated by Nucleic acid amplification typing kit. The percentage of T cell subgroup, CD4+ CD25+ Foxp3+T cells in peripheral blood was evaluated by flow cytometric analysis. Results T cell subsets showed no statistics difference between HPV negative and HPV positive patients (P ~ 0.05), but there were significant differences of T regulatory cells in two groups (P ~0.05). The percentage of CD4+ CD25+ Foxp3+ T cells of CD4+ T lymphocytes in peripheral blood from patients with cervical cancer were significantly different in comparison with the normal controls (P d0. 05). CD4+ CD25+ Foxp3+ Treg was positively correlated with HPV (r =0.613 , P 〈0.05). Conclu- sion There were no significant difference of immunologic function in patients with cervical cancer and health people. Treg is closely related to HPV persistent infection and tumor immune escape in patients with cervical cancer.
出处 《新疆医科大学学报》 CAS 2013年第12期1749-1752,共4页 Journal of Xinjiang Medical University
基金 新疆地方病分子生物学实验室开放课题(XJDX0208-2009-03)
关键词 宫颈癌 调节性T细胞 人乳头瘤病毒 cervical cancer T regulatory cell human papilloma virus
  • 相关文献

参考文献14

  • 1詹爱琴,刘佩芝.CD4^+CD25^+调节性T细胞在病毒感染中的免疫调节机制[J].微生物学免疫学进展,2008,36(3):70-73. 被引量:4
  • 2Cabrera R, Tu Z, Xu Y, et al. An immunomodulatory role for CD4+ CD25+-regulatory T lymphocytes in hepatitis C virus infection[J].Hepatology, 2004, 40(5): 1062-1071.
  • 3姜淑清,土送爱,周俊兰,买热木尼沙汗,碧佳娜提,茹仙姑丽,沙来买提,徐雪,海日尼沙汗,艾木热汗.新疆策勒县妇女病现状调查与分析[J].中国妇幼保健,2006,21(4):524-526. 被引量:50
  • 4古扎丽努尔.阿不力孜,帕提曼.米吉提,李庭芳,程静新,李华,路玲.HPV各亚型在新疆各地区维吾尔族宫颈癌患者中的分布研究[J].新疆医科大学学报,2009,32(5):513-517. 被引量:16
  • 5Suvas S, Azkur AK, Kim BS, et al. CD4+ CD25+ regulatory T cells control the severity of viral immunoinfiammatory lesions[J].J Immunol,2004, 172(7) :4123-4132.
  • 6Liyanage UK, Goedegebuure PS, Moore TT,et al. Increased prevalence of regulatory T cells (Treg) is induced by pancreas adenocarcinoma[J].J Immunother, 2006,29 (4) : 416-424.
  • 7Wolf AM,Wolf D, Steurer M,et al. Increase of regulatory T cells in the peripheral blood of cancer patients[J].Clin Cancer Res,2003:9(2):602-612.
  • 8Ormandy LA, Hillemann T, Wedemeyer H, et al. Increasedp- opulations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma [J]. Cancer Res, 2005,65 ( 6 ) : 2457-2464.
  • 9Patel S, Chiplunkar S. Host immune responses to cervical cancer[J].Curr Opin Obstet Gynecol, 2009,21 (1):54-59.
  • 10Roy S, Barik S, Banerjee S, et al. Neem leaf glyeoprotein o- vercomes indoleamine 2,3 dioxygenase mediated tolerance in dendritic cells by attenuating hyperactive regulatory T cells in cervical cancer stage IIIB patients[J].Hum Immunol, 2013, 74(8) : 1015-1023.

二级参考文献41

  • 1王金桃,高尔生,程玉英,闫建文,丁玲.宫颈癌危险因素病例对照研究[J].中国公共卫生,2004,20(2):161-162. 被引量:37
  • 2姜淑清,土送爱,周俊兰,买热木尼沙汗,碧佳娜提,茹仙姑丽,沙来买提,徐雪,海日尼沙汗,艾木热汗.新疆策勒县妇女病现状调查与分析[J].中国妇幼保健,2006,21(4):524-526. 被引量:50
  • 3李庭芳,古力娜.库尔班,古丽沙热,贺国丽,王涛,海日古丽,王振华.新疆伽师县夏普桃勒乡妇女子宫颈癌防治研究[J].新疆医学院学报,1996,19(3):199-203. 被引量:64
  • 4Clifford GM, Smith JS, Plummer M, et al. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis[J]. Br J Cancer,2003, 88(1) : 63-73.
  • 5Kin CJ, Jeong JK, Park M, et al. HPV oligonucleotide microarray - based deteetion of HPV genotypes in cervical neoplastielestions[J]. Gynecol Oncol,2003,89(2) :210-217.
  • 6Nagpal JK, Sahai S, Das BR. P53 codon 72 polymorphism and susceptibility to development of human papilloma virus 2 associated cervical cancer in Indian women[J]. Eur J Clin Invest, 2002, 32(12):943-948.
  • 7Das BC, Sharma JK, Gopalkrishna V, et al. A high frequency of human papillomavirus DNA sequences in cervical carcinomas t of Indian women as revealed by Southern blot hybridization and polymerase chain reaction[J].J Med Virol , 1992,36 : 239-245.
  • 8Agnantis NJ, Sotiriadis A, Paraskevaidis E. The current status of HPV DNA testing[J]. Eur J Gynaecol Oncol, 2003,24 (5) :351-356.
  • 9Ng'andwel C, Lowe JJ, Richards PJ, et al. The distribution of sexually-transmitted human papillomaviruses in HIV positive and negative patients in Zambia, Africa[J]. BMC Infect Dis,2007, 7(77) :1471-1492.
  • 10LO KW, Wong YF, Chan MK, et al. Prevlence of human papillomavirus in cervical cancer :a multicenter srudy in China[J]. Int J Cancer,2002,100(3) : 327-331.

共引文献63

同被引文献88

引证文献8

二级引证文献137

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部